Historical mck News Stories
McKesson Moves: Financing, AI Gains, Med-Surg Spin
Recent early-April 2026 disclosures show McKesson arranging senior secured financing while highlighting strong specialty revenue growth and expanding AI use in CoverMyMeds. Management is advancing the Medical‑Surgical (Med‑Surg) separation with leadership in place. These concrete developments improve liquidity positioning and reinforce McKesson’s shift toward higher-margin specialty and health‑IT services—factors investors should monitor as they affect MCK’s strategic trajectory.
McKesson Boosts Yield; CMS OKs Clinical Registry
McKesson announced a $0.82 quarterly dividend and received CMS designation for its Practice Insights platform as a Qualified Clinical Data Registry. Together these concrete developments strengthen McKesson’s income profile and health‑IT positioning, with potential near‑term support for MCK stock.
McKesson Hits Records on Strong Specialty Sales Q3
McKesson (MCK) reached consecutive 52-week highs after reporting robust fiscal Q3 results driven by specialty and oncology growth, rising GLP‑1 distribution, and strategic portfolio moves including the Medical‑Surgical separation and exit from Europe. Operational efficiencies, prescription technology momentum, and expanded oncology networks underpin the breakout.
McKesson Raises FY26 Guidance After Strong Q3 Beat
McKesson reported a powerful Q3 FY2026 with $106.2B revenue, raised adjusted EPS guidance to $38.80–$39.20, completed its Norwegian exit, and maintained dividends—moves that sharpen its North America focus and bolster investor confidence amid increasing specialty logistics competition.
McKesson Q3 Beat Fuels Oncology & AI Upside —MCK!!
McKesson reported a Q3 earnings beat and raised full-year EPS guidance, driven by strong oncology and North American pharmaceuticals performance, progress toward the Medical‑Surgical spin‑off, and continued investments in automation and health IT. These concrete developments accelerated investor interest while GLP‑1 volume dynamics and regulatory exposure remain key risks.
McKesson Rally: Q3 Beat, Guidance Lift Sparks Now!
McKesson (MCK) jumped after a Feb. 4 Q3 beat, raised fiscal-year guidance, and announced strategic exits and a dividend. Technical momentum (RS Rating surge) and strong peer results supported the move—investors should watch for pullbacks to support levels and monitor cash flow and margin trends.